Skip to main content
Erschienen in: Urolithiasis 4/2003

01.08.2003 | Original Paper

The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium

verfasst von: Zhenhua Lin, Hankyeom Kim, Hongseok Park, Youngsik Kim, Jun Cheon, Insun Kim

Erschienen in: Urolithiasis | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Abstract

The bcl-2 proto-oncogene plays a key role in cell longevity by preventing apoptosis. Bcl-2 is important in developing and maintaining the normal function of lymphoid and epithelial tissues. The bcl-6 protein is a 96 kDa nuclear protein selectively expressed in mature B cells within normal germinal centers as well as in their transformed counterparts in diffuse large B cell lymphoma. Recently, the bcl-6 protein has also been reported to be expressed in normal skin and epidermal neoplasms. In this study, 47 cases of transitional cell carcinomas (TCCs) were immunohistochemically studied for bcl-2 and bcl-6 protein expression. The results showed that bcl-2 was expressed only on basal layer cells, whereas bcl-6 expression was restricted to the superficial layers in the normal transitional epithelium. Von Brunn's nests showed strong immunostaining to bcl-2, but were negative to bcl-6. Among 47 TCCs, 15 (32.6%) and 29 (61.7%) cases were positive for bcl-2 and bcl-6, respectively. Compared with the normal transitional epithelium, the expression of bcl-2 was significantly decreased, whereas bcl-6 expression was significantly increased in TCCs. Additionally, the strong expression of bcl-6 had a positive correlation with the histopathologic grade of TCC. In conclusion, bcl-2 and bcl-6 proteins may play a role in the pathogenesis of TCCs, and bcl-6 expression reflects histopathologic grade.
Literatur
1.
Zurück zum Zitat Berek C, Berger A, Apel M (1991) Maturation of the immune response in germinal centers. Cell 67: 1121PubMed Berek C, Berger A, Apel M (1991) Maturation of the immune response in germinal centers. Cell 67: 1121PubMed
2.
Zurück zum Zitat Bhargava V, Kell DL, Rijin M van de, Warnke RA (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145: 535PubMed Bhargava V, Kell DL, Rijin M van de, Warnke RA (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145: 535PubMed
3.
Zurück zum Zitat Cattoretti G, Chang CC, Cechova K, Zhang JD, Ye BH, Falini B, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R (1995) Bcl-6 protein is expressed in germinal-center B cells. Blood 86: 45PubMed Cattoretti G, Chang CC, Cechova K, Zhang JD, Ye BH, Falini B, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R (1995) Bcl-6 protein is expressed in germinal-center B cells. Blood 86: 45PubMed
4.
Zurück zum Zitat Eissa S, Seada LS (1998) Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin Chem 44: 1423PubMed Eissa S, Seada LS (1998) Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin Chem 44: 1423PubMed
5.
Zurück zum Zitat Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F, Bevilacqua G (1995) Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 71: 1003PubMed Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F, Bevilacqua G (1995) Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 71: 1003PubMed
6.
Zurück zum Zitat Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A (2000) Msh2, MIh1, Fhit, p53, bcl-2, and bax espression in invasive and, in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 6: 3600PubMed Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A (2000) Msh2, MIh1, Fhit, p53, bcl-2, and bax espression in invasive and, in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 6: 3600PubMed
7.
Zurück zum Zitat Jacob J, Kelsoe G, Rajewsky K, Weiss U (1991) Intraclonal generation of antibody mutants in germinal centers. Nature 354: 389PubMed Jacob J, Kelsoe G, Rajewsky K, Weiss U (1991) Intraclonal generation of antibody mutants in germinal centers. Nature 354: 389PubMed
8.
Zurück zum Zitat Kanazawa N, Moriyama M, Onizuka T, Sugawara K, Mori S (1997) Expression of bcl-6 protein in normal skin and epidermal neoplasms. Pathol Int 47: 600PubMed Kanazawa N, Moriyama M, Onizuka T, Sugawara K, Mori S (1997) Expression of bcl-6 protein in normal skin and epidermal neoplasms. Pathol Int 47: 600PubMed
9.
Zurück zum Zitat King ED, Matesson J, Jacobs SC, Kyprianou N (1996) Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol 155: 316PubMed King ED, Matesson J, Jacobs SC, Kyprianou N (1996) Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol 155: 316PubMed
10.
Zurück zum Zitat Kirsh EJ, Baunoch DA, Stadler WM (1998) Expression of bcl-2 and bcl-X in bladder cancer. J Urol 159: 1348PubMed Kirsh EJ, Baunoch DA, Stadler WM (1998) Expression of bcl-2 and bcl-X in bladder cancer. J Urol 159: 1348PubMed
11.
Zurück zum Zitat Lipponen PK, Aaltomma S, Eskeline M (1996) Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumors. Histopathology 28: 135PubMed Lipponen PK, Aaltomma S, Eskeline M (1996) Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumors. Histopathology 28: 135PubMed
12.
Zurück zum Zitat Liu HF, Liu WW, Fang DC, Men RP (1998) Expression of bcl-2 protein in gastric carcinoma and its significance. World J Gastroenterol 4: 228 Liu HF, Liu WW, Fang DC, Men RP (1998) Expression of bcl-2 protein in gastric carcinoma and its significance. World J Gastroenterol 4: 228
13.
Zurück zum Zitat Masuda M, Takano Y, Iki M, Asakura T, Hashiba T, Noguchi S, Hosaka M (1997) Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis. J Urol 158: 750PubMed Masuda M, Takano Y, Iki M, Asakura T, Hashiba T, Noguchi S, Hosaka M (1997) Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis. J Urol 158: 750PubMed
14.
Zurück zum Zitat Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA (1998) The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlate. Hum Pathol 29: 146PubMed Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA (1998) The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlate. Hum Pathol 29: 146PubMed
15.
Zurück zum Zitat Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H, Mori S (1995) Bcl gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86: 28PubMed Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H, Mori S (1995) Bcl gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86: 28PubMed
16.
Zurück zum Zitat Orntoft TF, Wolf H. (1998) Molecular alterations in bladder cancer. Urol Res 26: 223PubMed Orntoft TF, Wolf H. (1998) Molecular alterations in bladder cancer. Urol Res 26: 223PubMed
17.
Zurück zum Zitat Seyfert VL, Allman D, He Y, Staudt LM (1996) Transcriptional repression by the proto-oncogene bcl-6. Oncogene 12: 2331PubMed Seyfert VL, Allman D, He Y, Staudt LM (1996) Transcriptional repression by the proto-oncogene bcl-6. Oncogene 12: 2331PubMed
18.
Zurück zum Zitat Wu TT, Chen JH, Lee YH, Huang JK (2000) The role of bcl-2, p53, and Ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma. J Urol 163: 758PubMed Wu TT, Chen JH, Lee YH, Huang JK (2000) The role of bcl-2, p53, and Ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma. J Urol 163: 758PubMed
19.
Zurück zum Zitat Ye BH, Lista F, Coco FL, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R (1993) Alterations of a zinc finger-encoding gene, bcl6, in diffuse large-cell lymphoma. Science 262: 747PubMed Ye BH, Lista F, Coco FL, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R (1993) Alterations of a zinc finger-encoding gene, bcl6, in diffuse large-cell lymphoma. Science 262: 747PubMed
20.
Zurück zum Zitat Ye D, Li H, Qian SX, Zheng JH, Ma YJ (1998) bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection. J Urol 160: 2025PubMed Ye D, Li H, Qian SX, Zheng JH, Ma YJ (1998) bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection. J Urol 160: 2025PubMed
21.
Zurück zum Zitat Yoshida T, Fukuda T, Okabe S, Hatano M, Miki T, Hirosawa S, Miyasaka N, Isono K, Tokuhisa T (1996) The bcl-6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage. Biochem Biophys Res Commun 228: 216CrossRefPubMed Yoshida T, Fukuda T, Okabe S, Hatano M, Miki T, Hirosawa S, Miyasaka N, Isono K, Tokuhisa T (1996) The bcl-6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage. Biochem Biophys Res Commun 228: 216CrossRefPubMed
Metadaten
Titel
The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium
verfasst von
Zhenhua Lin
Hankyeom Kim
Hongseok Park
Youngsik Kim
Jun Cheon
Insun Kim
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 4/2003
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-003-0324-3

Weitere Artikel der Ausgabe 4/2003

Urolithiasis 4/2003 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.